Doxorubicin HCL

Doxorubicin HCL
Product Description

Oncology API, DMF approved,CEP approved

Zhejiang Hisun Pharmaceutical Co.,Ltd.

  • CN
  • 2015
    On CPHI since
Specifications
  • Selling Points
    International Approvals/Standards; Quality Service
  • Supplied from
    China
  • Measured In
    g

Zhejiang Hisun Pharmaceutical Co.,Ltd.

  • CN
  • 2015
    On CPHI since

More Products from Zhejiang Hisun Pharmaceutical Co.,Ltd. (40)

  • Methotrexate

    Product Methotrexate

    Oncology API, DMF approved, CEP approved
  • Mesna

    Product Mesna

    Oncology API, DMF approved
  • Letrozole

    Product Letrozole

    Oncology API, DMF approved, CEP approved.
  • Idarubicin HCL

    Product Idarubicin HCL

    Oncology API, DMF approved.
  • Fludarabine Phosphate

    Product Fludarabine Phosphate

    Oncology API, DMF approved, CEP approved.
  • Epirubicin HCL

    Product Epirubicin HCL

    Oncology API, DMF approved,CEP approved.
  • Dactinomycin

    Product Dactinomycin

    Oncology API, DMF approved.
  • Cytatabine

    Product Cytatabine

    Oncology API, DMF approved, CEP approved.
  • Fipronil (bsi,pa e-iso)

    Product Fipronil (bsi,pa e-iso)

    Zhejiang Hisun Pharmaceutical Co.,Ltd. offers a wide range of products which includes Fipronil (bsi,pa e-iso). It belongs to TC Intermediate category. Contact us for more information.
  • DACTINOMYCIN FOR INJECTIONS

    Product DACTINOMYCIN FOR INJECTIONS

    HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA ,  FOR FURTHER INFORMATION PLS. CONTACT [email protected]
  • DAPTOMYCIN FOR INJECTION

    Product DAPTOMYCIN FOR INJECTION

    HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA ,  FOR FURTHER INFORMATION PLS. CONTACT [email protected]
  • DAUNORUBICIN FOR INJECTION

    Product DAUNORUBICIN FOR INJECTION

    HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA ,  FOR FURTHER INFORMATION PLS. CONTACT [email protected]